Meridian Bioscience/ US5895841014 /
2023-01-30 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
33.98USD | - | 112,605 Turnover: 3.83 mill. |
-Bid Size: - | -Ask Size: - | 1.5 bill.USD | - | 35.02 |
Assets
|
2009 US GAAP in mill. USD |
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 20.5000 | 21.2000 | 26.5000 | 26.2000 | 26.1000 | ||||||
Intangible Assets | 7.3000 | 13.3000 | 10.9000 | 10.3000 | 8.1000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 23.3000 | 28.4000 | 32.7000 | 31.7000 | 34.8000 | ||||||
Accounts Receivable | 27 | 22.1000 | 24.8000 | 24.2000 | 26.2000 | ||||||
Cash and Cash Equivalents | 54 | 37.9000 | 23.6000 | 31.6000 | 44.3000 | ||||||
Current Assets | 117.1000 | 95.3000 | 90.4000 | 96.6000 | 114.1000 | ||||||
Total Assets | 156 | 154.6000 | 155.5000 | 161.4000 | 176.7000 |
Liabilities
|
2009 US GAAP in mill. USD |
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 6.9000 | 4.5000 | 5.5000 | 5.8000 | 5.6000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 1.3000 | 2.8000 | 1.7000 | .2000 | - | ||||||
Liabilities | 18.1000 | 17.3000 | 17 | 18.7000 | 21.7000 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 137.9000 | 138.5000 | 138.5000 | 142.7000 | 155 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 156 | 154.6000 | 155.5000 | 161.4000 | 176.7000 |
Income Statement
|
2009 US GAAP in mill. USD |
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 148.3000 | 143 | 159.7000 | 173.5000 | 188.7000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 48.8000 | 41.1000 | 40 | 49.3000 | 57.3000 | ||||||
Interest Income | .5000 | .1000 | .1000 | - | .0400 | ||||||
Income Before Taxes | 49.3000 | 41.4000 | 40.5000 | 49.7000 | 57.4000 | ||||||
Income Taxes | 16.6000 | 14.8000 | 13.7000 | 16.3000 | 19.3000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 32.8000 | 26.6000 | 26.8000 | 33.4000 | 38 |
Per Share
Cash Flow
|
2009 US GAAP in mill. USD |
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 32.5000 | 29.7000 | 22.5000 | 42.4000 | 44.4000 | ||||||
Cash Flow from Investing Activities | -3.3000 | -16.3000 | -9.2000 | -4.4000 | -3.3000 | ||||||
Cash Flow from Financing | -24.6000 | -29.2000 | -27.5000 | -30.7000 | -28.6000 | ||||||
Decrease / Increase in Cash | 4.7000 | -16.2000 | -14.3000 | 8 | 12.7000 | ||||||
Employees | - | - | - | - | - |